Ventricular assist devices for postcardiotomy cardiogenic shock

A combined registry experience

Walter Pae, C. A. Miller, Y. Matthews, W. S. Pierce, L. H. Edmunds, C. E.A. Cabrol, R. Hetzer, G. J. Magovern, J. D. Hill

Research output: Contribution to journalArticle

160 Citations (Scopus)

Abstract

Data submitted voluntarily to the combined registry since its inception in 1985 to December 31, 1990, on the use of ventricular assist devices for postcardiotomy cardiogenic shock in 965 patients were analyzed. Approximately 45% of patients were weaned from temporary circulatory assistance and 24.6% reached hospital discharge regardless of the original operation. In 90% of patients who were discharged from the hospital, circulatory support was able to be discontinued by 1 week. Rates of weaning and discharge were statistically different and favored those patients requiring univentricular support only. Results were equal whether nonpulsatile centrifugal or pulsatile pneumatic devices were used for support. Although complications were frequent and multiple during assist pumping, patient variables including age greater than 70 years rather than direct complications caused by circulatory support were likely to affect overall outcome. In patients achieving hospital discharge, 2-year actuarial survival was 82% with 86% of patients being in New York Heart Association functional class I or II. In rare instances of device dependency in 43 patients (4.5%) with no contraindications to transplantation, 32 (74.4%) underwent bridge to cardiac transplant and 20 (62.5%) were discharged. This multiinstitutional experience would continue to support the use of ventricular assist devices in postcardiotomy cardiogenic shock.

Original languageEnglish (US)
Pages (from-to)541-553
Number of pages13
JournalJournal of Thoracic and Cardiovascular Surgery
Volume104
Issue number3
StatePublished - Jan 1 1992

Fingerprint

Heart-Assist Devices
Cardiogenic Shock
Registries
Equipment and Supplies
Weaning
Transplantation
Transplants
Survival

All Science Journal Classification (ASJC) codes

  • Surgery
  • Pulmonary and Respiratory Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Pae, W., Miller, C. A., Matthews, Y., Pierce, W. S., Edmunds, L. H., Cabrol, C. E. A., ... Hill, J. D. (1992). Ventricular assist devices for postcardiotomy cardiogenic shock: A combined registry experience. Journal of Thoracic and Cardiovascular Surgery, 104(3), 541-553.
Pae, Walter ; Miller, C. A. ; Matthews, Y. ; Pierce, W. S. ; Edmunds, L. H. ; Cabrol, C. E.A. ; Hetzer, R. ; Magovern, G. J. ; Hill, J. D. / Ventricular assist devices for postcardiotomy cardiogenic shock : A combined registry experience. In: Journal of Thoracic and Cardiovascular Surgery. 1992 ; Vol. 104, No. 3. pp. 541-553.
@article{78b612d232a9404a8b3fd55acbbec9c5,
title = "Ventricular assist devices for postcardiotomy cardiogenic shock: A combined registry experience",
abstract = "Data submitted voluntarily to the combined registry since its inception in 1985 to December 31, 1990, on the use of ventricular assist devices for postcardiotomy cardiogenic shock in 965 patients were analyzed. Approximately 45{\%} of patients were weaned from temporary circulatory assistance and 24.6{\%} reached hospital discharge regardless of the original operation. In 90{\%} of patients who were discharged from the hospital, circulatory support was able to be discontinued by 1 week. Rates of weaning and discharge were statistically different and favored those patients requiring univentricular support only. Results were equal whether nonpulsatile centrifugal or pulsatile pneumatic devices were used for support. Although complications were frequent and multiple during assist pumping, patient variables including age greater than 70 years rather than direct complications caused by circulatory support were likely to affect overall outcome. In patients achieving hospital discharge, 2-year actuarial survival was 82{\%} with 86{\%} of patients being in New York Heart Association functional class I or II. In rare instances of device dependency in 43 patients (4.5{\%}) with no contraindications to transplantation, 32 (74.4{\%}) underwent bridge to cardiac transplant and 20 (62.5{\%}) were discharged. This multiinstitutional experience would continue to support the use of ventricular assist devices in postcardiotomy cardiogenic shock.",
author = "Walter Pae and Miller, {C. A.} and Y. Matthews and Pierce, {W. S.} and Edmunds, {L. H.} and Cabrol, {C. E.A.} and R. Hetzer and Magovern, {G. J.} and Hill, {J. D.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "104",
pages = "541--553",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "3",

}

Pae, W, Miller, CA, Matthews, Y, Pierce, WS, Edmunds, LH, Cabrol, CEA, Hetzer, R, Magovern, GJ & Hill, JD 1992, 'Ventricular assist devices for postcardiotomy cardiogenic shock: A combined registry experience', Journal of Thoracic and Cardiovascular Surgery, vol. 104, no. 3, pp. 541-553.

Ventricular assist devices for postcardiotomy cardiogenic shock : A combined registry experience. / Pae, Walter; Miller, C. A.; Matthews, Y.; Pierce, W. S.; Edmunds, L. H.; Cabrol, C. E.A.; Hetzer, R.; Magovern, G. J.; Hill, J. D.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 104, No. 3, 01.01.1992, p. 541-553.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ventricular assist devices for postcardiotomy cardiogenic shock

T2 - A combined registry experience

AU - Pae, Walter

AU - Miller, C. A.

AU - Matthews, Y.

AU - Pierce, W. S.

AU - Edmunds, L. H.

AU - Cabrol, C. E.A.

AU - Hetzer, R.

AU - Magovern, G. J.

AU - Hill, J. D.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Data submitted voluntarily to the combined registry since its inception in 1985 to December 31, 1990, on the use of ventricular assist devices for postcardiotomy cardiogenic shock in 965 patients were analyzed. Approximately 45% of patients were weaned from temporary circulatory assistance and 24.6% reached hospital discharge regardless of the original operation. In 90% of patients who were discharged from the hospital, circulatory support was able to be discontinued by 1 week. Rates of weaning and discharge were statistically different and favored those patients requiring univentricular support only. Results were equal whether nonpulsatile centrifugal or pulsatile pneumatic devices were used for support. Although complications were frequent and multiple during assist pumping, patient variables including age greater than 70 years rather than direct complications caused by circulatory support were likely to affect overall outcome. In patients achieving hospital discharge, 2-year actuarial survival was 82% with 86% of patients being in New York Heart Association functional class I or II. In rare instances of device dependency in 43 patients (4.5%) with no contraindications to transplantation, 32 (74.4%) underwent bridge to cardiac transplant and 20 (62.5%) were discharged. This multiinstitutional experience would continue to support the use of ventricular assist devices in postcardiotomy cardiogenic shock.

AB - Data submitted voluntarily to the combined registry since its inception in 1985 to December 31, 1990, on the use of ventricular assist devices for postcardiotomy cardiogenic shock in 965 patients were analyzed. Approximately 45% of patients were weaned from temporary circulatory assistance and 24.6% reached hospital discharge regardless of the original operation. In 90% of patients who were discharged from the hospital, circulatory support was able to be discontinued by 1 week. Rates of weaning and discharge were statistically different and favored those patients requiring univentricular support only. Results were equal whether nonpulsatile centrifugal or pulsatile pneumatic devices were used for support. Although complications were frequent and multiple during assist pumping, patient variables including age greater than 70 years rather than direct complications caused by circulatory support were likely to affect overall outcome. In patients achieving hospital discharge, 2-year actuarial survival was 82% with 86% of patients being in New York Heart Association functional class I or II. In rare instances of device dependency in 43 patients (4.5%) with no contraindications to transplantation, 32 (74.4%) underwent bridge to cardiac transplant and 20 (62.5%) were discharged. This multiinstitutional experience would continue to support the use of ventricular assist devices in postcardiotomy cardiogenic shock.

UR - http://www.scopus.com/inward/record.url?scp=0026757227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026757227&partnerID=8YFLogxK

M3 - Article

VL - 104

SP - 541

EP - 553

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 3

ER -